Prescription pattern of diabetes mellitus with comorbid condition
Journal Title: International Journal of Research in Pharmacology & Pharmacotherapeutics (IJRPP) - Year 2017, Vol 6, Issue 3
Abstract
Aim This study is aimed to assess the prescription pattern in DM patients with co morbid condition, because prescription pattern could lead to worsening of disease and increased risk of complications. The specific and general aspects of diabetic patients including the available dosage forms, to patients, drug interactions observed and common co morbities seen in diabetic patients, all add to difficulties facing by the practitioner who treats them. Due to the above reasons the study was designed to help minimize the prescription errors, render safe dosage regimen, by carefully monitoring the patients glyceminc control and other responses towards therapy, finally improving the quality of life. Methodology This is a prospective observational study conducted over a period of six months using questionnaires as a tool. The study was conducted at Nephrology ward of AWARE GLOBAL HOSPITAL LB. NAGAR. Patients who admitted to the general ward of the hospital during a six-month period from October 2016 to March 2017 are enrolled. Results Based on inclusion and exclusion criteria, 98 patients were selected from the inpatient department over a period of 6 months for the present study. Among 98 patients The gender distribution found in the following study was males (64%) and females (36%), the age distribution was found to be 25-35 yrs (4%),35-45yrs (12%),45-55 yrs (24%), 55- 65yrs (35%), 65-75 yrs (17%) ,75-85 yrs (8%). Of the total 98 cases enrolled the co morbid conditions found were Hypertension (76%), hypothyroidism (16%) and chronic kidney disease (15%). A total of 464 drugs were prescribed during the study period. 102 (22%) antidiabetics, 72(15.5%) antihypertensives, 59(12.72%) multivitamins, 46 (9.9%) antiplatelets, 20(4.31%) statins and 165(35.5%) miscellaneous drugs were prescribed. Conclusion The final report drawn from a total of 98 cases with the primary condition “DIABETES MELLITUS TYPE -II” the major co-morbid condition found was HYPETENSION (76 cases) in the study population. The standard therapy which showed good control for the condition Diabetes + Hypertension given was: a) Ca+2 channel blockers (22.45% usage) eg. Amlodipine b) β-Blockers (15.31%) eg. Metoprolol c) Biguanides (43%) eg. Metformin d) Human Mixtard Insulin (25%)
Authors and Affiliations
Padala Srikanth
Keywords
Related Articles
- EP ID EP413168
- DOI -
- Views 95
- Downloads 0
Study of invitro antioxidant, antidiabetic and antibacterial activity of Clausena anisata (Willd). Hook (Rutaceae) leaf extracts
Clausena anisata (Willd.) Hook of family Rutaceae, is a deciduous shrub or small tree that contains a wide array of compounds exhibiting diverse range of bioactivity. Leaf extracts are traditionallly used as effective r...
Astashine capsules: an excellent choice to boost immune system.
Astaxanthin is a naturally occurring carotenoid which is derived from the microalgae Haematococcus pluvialis. As well as being the most powerful antioxidant known to science, it also has potent anti-inflammatory properti...
Assessment of level of knowledge and to explore association between knowledge and diabetic complications among type 2 diabetes mellitus patients
Aim To assess the level of knowledge and to explore the association between knowledge and diabetes complications among patient with type 2 Diabetes Mellitus. Methods A cross sectional study was conducted among 428 pati...
Development of novel gastroretentive mucoadhesive pulsetile tablets for zileuton
In the present research work pulsatile drug delivery system of Zileuton tablets were formulated by employing compression coating technology. Initially the core tablets were prepared by 30% concentrations of super disinte...
Antioxidant and Antitumor Activities on Catunaregum spinosa.
The methanol extract of Catunaregum spinosa (MECS) were evaluated for antitumor activity and antioxidant activity against Dalton’s ascites lymphoma (DAL) bearing Swiss albino mice. The extract was administered at the d...